EUVIMEDEUVIMED entdecken
Crossref

Post-chemotherapy robot-assisted retroperitoneal lymph node dissection for metastatic germ cell tumors: safety and perioperative outcomes

Nicolas Branger, Franck Bladou, Gregory Verhoest, Sophie Knipper, Grégoire Robert, Jean-Christophe Bernhard, Jean-Baptiste Beauval, Abderrahmane Khaddad, Anne Mauger De Varennes, Aude Fléchon, Jochen Walz, Anne-Sophie Bageot und 4 weitere

World Journal of Urology · 2023

DOI: 10.1007/s00345-023-04536-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Urology, 2023. Verfasst von Nicolas Branger und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Institut Paoli Calmettes Cancer Center, Marseille, France. brangern@ipc.unicancer.fr. Hauptthemen laut MEDLINE: Robotics, Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To evaluate the feasibility, safety, and early oncologic outcomes after post-chemotherapy robot-assisted retroperitoneal lymph node dissection (PC-RARPLND) for metastatic germ cell tumors (mGCT). METHODS: We retrospectively analyzed patients from four tertiary centers who underwent PC-RARPLND for mGCT, from 2011 to 2021. Previous treatment of mGCT, intraoperative and postoperative complications, and early oncologic outcomes were assessed. RESULTS: Overall, 66 patients were included. The majority of patients had non-seminoma mTGCT (89%). Median size of retroperitoneal lymph node (RLN) before surgery was 26 mm. Templates of PC-RARPLND were left modified, right modified, and full bilateral in 56%, 27%, and 14%, respectively. Median estimated blood loss and length of stay were 50 mL [50-150] and 2 [1-3] days. Four patients (6.1%) had a vascular injury, only one with significant blood loss and conversion to open surgery (OS). Two other patients had a conversion to OS for difficulty of dissection. No patient had transfusion, most frequent complications were ileus (10.6%) and symptomatic lymphorrea (7.6%) and no complications grade IIIb or more occurred. With a median follow-up of 16 months, two patients had a relapse, all outside of the surgical template (one in the retrocrural space with reascending markers, one in lungs). CONCLUSION: PC-RARPLND is a challenging surgery. In expert centers and for selected patients, it seemed safe and feasible, with a low morbidity. Further prospective evaluation of this procedure and long-term oncologic results are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RoboticsTesticular NeoplasmsNeoplasms, Germ Cell and EmbryonalMaleHumansRetrospective StudiesLymphatic MetastasisLymph Node ExcisionLymph NodesRetroperitoneal Space

Stichwörter der Autor:innen

Minimally invasive surgeryPost-chemotherapy robot-assisted retroperitoneal lymph node dissectionRobot-assisted retroperitoneal lymph node dissectionTesticular cancerTesticular germ cell tumor

Autor:innen und Institutionen

  • Department of Urology, Institut Paoli Calmettes Cancer Center, Marseille, France. brangern@ipc.unicancer.fr.
  • Department of Urology, CHU Bordeaux, Bordeaux, France.
  • Department of Urology, CHU Rennes, Rennes, France.
  • Department of Urology, Institut Paoli Calmettes Cancer Center, Marseille, France.
  • Department of Urology, CHU Toulouse, Toulouse, France.
  • Department of Oncology, Centre Léon Bérard, Lyon, France.

Zitieren

APA

Branger, N., Bladou, F., Verhoest, G., Knipper, S., Robert, G., Bernhard, J. C., Beauval, J. B., Khaddad, A., Mauger De Varennes, A., Fléchon, A., Walz, J., Bageot, A. S., Doumerc, N., Rouprêt, M., Murez, T., & French AFU Testicular Cancer Committee (2023). Post-chemotherapy robot-assisted retroperitoneal lymph node dissection for metastatic germ cell tumors: safety and perioperative outcomes. World Journal of Urology. https://doi.org/10.1007/s00345-023-04536-3

Vancouver

Branger N, Bladou F, Verhoest G, Knipper S, Robert G, Bernhard JC, et al. Post-chemotherapy robot-assisted retroperitoneal lymph node dissection for metastatic germ cell tumors: safety and perioperative outcomes. World Journal of Urology. 2023. doi:10.1007/s00345-023-04536-3

BibTeX
@article{Branger2023,
  author = {Branger, Nicolas and Bladou, Franck and Verhoest, Gregory and Knipper, Sophie and Robert, Grégoire and Bernhard, Jean-Christophe and Beauval, Jean-Baptiste and Khaddad, Abderrahmane and Mauger De Varennes, Anne and Fléchon, Aude and Walz, Jochen and Bageot, Anne-Sophie and Doumerc, Nicolas and Rouprêt, Morgan and Murez, Thibault and French AFU Testicular Cancer Committee, French AFU Testicular Cancer Committee},
  title = {Post-chemotherapy robot-assisted retroperitoneal lymph node dissection for metastatic germ cell tumors: safety and perioperative outcomes},
  journal = {World Journal of Urology},
  year = {2023},
  doi = {10.1007/s00345-023-04536-3}
}
Kostenlos starten →